Research map: Stromal Laminin Subunit Alpha 3 is a Novel Prognostic Marker for Breast Cancer

Back to the article

Papers in this map

  1. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets · Yingyao Zhou · 2019 · 16082 citations · Cited by this paper
  2. Augmented Reality Navigation-Assisted Laparoscopic Hepatectomy: A Retrospective Comparison of Anatomical and Non-anatomical Resection · 2026 · Related
  3. QuPath: Open source software for digital pathology image analysis · Peter Bankhead · 2017 · 9171 citations · Cited by this paper
  4. Serum Cystatin S (CST4): A Novel Prognostic Marker for Gastric Cancer · 2025 · Related
  5. Universal sample preparation method for proteome analysis · Jacek R. Wiśniewski · 2009 · 8883 citations · Cited by this paper
  6. Clinical Outcomes of Lenvatinib–Pembrolizumab in a High-Risk, Dual ICI-Refractory Melanoma Cohort · 2026 · Related
  7. Cancer statistics for the year 2020: An overview · Jacques Ferlay · 2021 · 5845 citations · Cited by this paper
  8. Effectiveness of Second-Line Pembrolizumab Monotherapy for the Treatment of Nonsmall Cell Lung Cancer: A Retrospective-Single Institution Study of 52 Vietnamese Patients · 2025 · Related
  9. TIMER2.0 for analysis of tumor-infiltrating immune cells · Taiwen Li · 2020 · 5797 citations · Cited by this paper
  10. Concurrent Tumor-Treating Fields and Chemoradiotherapy: Outcomes in Grade 4 Glioma Patients · 2025 · Related
  11. UALCAN: An update to the integrated cancer data analysis platform · Darshan Shimoga Chandrashekar · 2022 · 2638 citations · Cited by this paper
  12. Risk Factors for Febrile Neutropenia in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Undergoing Initial R-CHOP Treatment · 2026 · Related
  13. Proteogenomics connects somatic mutations to signalling in breast cancer · NCI CPTAC · 2016 · 1820 citations · Cited by this paper
  14. Contribution of TP53 and MDM4 Genetic Polymorphisms as a Risk Factor in Non-Hodgkin Lymphoma in Adult Egyptian Patients · 2025 · Related
  15. Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer · Balázs Győrffy · 2021 · 1772 citations · Cited by this paper
  16. The Effect of Bladder and Rectum Volume Changes on Exposed Organ Volume During Intensity-Modulated Radiotherapy for Cervical Cancer · 2025 · Related
  17. Therapeutic Targeting of the Tumor Microenvironment · Leire Bejarano · 2021 · 1742 citations · Cited by this paper
  18. Mechanism and Therapeutic Progress of One-Carbon Metabolic Key Enzyme: Serine Hydroxymethyltransferase 2 in Cancer · 2025 · Related
  19. Current and future perspectives of liquid biopsies in genomics-driven oncology · Ellen Heitzer · 2018 · 1597 citations · Cited by this paper
  20. Enfortumab Vedotin Plus Pembrolizumab Compared to Pembrolizumab and Standard Chemotherapy: Birds of a Feather Flock Together in Urothelial Cancer · 2025 · Related
  21. Extracellular vesicles as tools and targets in therapy for diseases · Mudasir A. Kumar · 2024 · 1315 citations · Cited by this paper
  22. Digital pathology and artificial intelligence in translational medicine and clinical practice · Vipul A. Baxi · 2021 · 599 citations · Cited by this paper
  23. Cancer treatments: Past, present, and future · Dmitriy Sonkin · 2024 · 525 citations · Cited by this paper
  24. Towards targeting the breast cancer immune microenvironment · Michael A. Harris · 2024 · 359 citations · Cited by this paper
  25. Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer · Moumita Kundu · 2024 · 243 citations · Cited by this paper
  26. St. Gallen 2013: Brief Preliminary Summary of the Consensus Discussion · Nadia Harbeck · 2013 · 176 citations · Cited by this paper
  27. QuPath: The global impact of an open source digital pathology system · Matthew P. Humphries · 2021 · 125 citations · Cited by this paper
  28. Origin and function of tumor stroma fibroblasts · Georgia Xouri · 2009 · 113 citations · Cited by this paper
  29. Laminin-332-Rich Tumor Microenvironment for Tumor Invasion in the Interface Zone of Breast Cancer · Baek Gil Kim · 2011 · 98 citations · Cited by this paper
  30. Molecular Detection of Noninvasive and Invasive Bladder Tumor Tissues and Exfoliated Cells by Aberrant Promoter Methylation of Laminin-5 Encoding Genes · Ubaradka G. Sathyanarayana · 2004 · 94 citations · Cited by this paper
  31. Inhibiting intracellular CD28 in cancer cells enhances antitumor immunity and overcomes anti-PD-1 resistance via targeting PD-L1 · Zhen Yang · 2024 · 79 citations · Cited by this paper
  32. Motility Induction in Breast Carcinoma by Mammary Epithelial Laminin 332 (Laminin 5) · Philip M. Carpenter · 2009 · 59 citations · Cited by this paper
  33. Comprehensive analysis of oncogenic determinants across tumor types via multi-omics integration · Saba Ubaid · 2025 · 58 citations · Cited by this paper
  34. Cancer therapy resistance mediated by cancer-associated fibroblast-derived extracellular vesicles: biological mechanisms to clinical significance and implications · Zhengjun Lin · 2024 · 50 citations · Cited by this paper
  35. Long Non-coding RNA LINC00628 Interacts Epigenetically with the LAMA3 Promoter and Contributes to Lung Adenocarcinoma · Shufeng Xu · 2019 · 47 citations · Cited by this paper
  36. Adhesion and Migration, the Diverse Functions of the Laminin α3 Subunit · Kevin J. Hamill · 2009 · 46 citations · Cited by this paper
  37. Evaluation of the diagnostic ability of laminin gene family for pancreatic ductal adenocarcinoma · Chengkun Yang · 2019 · 36 citations · Cited by this paper
  38. The role of laminins in cancer pathobiology: a comprehensive review · Elena Nonnast · 2025 · 36 citations · Cited by this paper
  39. Migration of breast cancer cell lines in response to pulmonary laminin 332 · Philip M. Carpenter · 2016 · 28 citations · Cited by this paper

Source: OpenAlex (CC0)